NCT06858787View on ClinicalTrials.gov

Validating CGM for GDM

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 2, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Gestational Diabetes Mellitus (GDM)
Interventions
DEVICE

Continuous glucose monitor

Device is a remote sensor applied to the upper extremity that continuously samples glucose of interstitial fluid and uploading results to a mobile application.

Trial Locations (1)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER